The Annual General Meeting will be held at 1.00 p.m. on 23 April 2025 at the Max Rayne Auditorium, The Royal Society of Medicine, 1 Wimpole Street, Westminster, London W1G 0AE.
The company’s shares traded at an average discount of 11.5% over the year. Since this exceeds 10%, the Directors, as outlined in the Interim Report, will propose an ordinary resolution at the AGM in April, seeking shareholder approval for the Company’s continuation. The Board recommends unanimously that shareholders vote in favour of the resolution.
